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Abstract
The	sodium/calcium	exchangers	(NCX)	use	the	extracellular	sodium	concentration	to	facilitate	the
extrusion	of	calcium	out	of	the	cell.	Alongside	the	plasma	membrane	Ca2+-ATPase	(PMCA)	and
sarcoplasmic/endoplasmic	reticulum	Ca2+-ATPase	(SERCA),	as	well	as	the	sodium/potassium/calcium
exchangers	(NKCX,	SLC24	family),	NCX	allow	recovery	of	intracellular	calcium	back	to	basal	levels
after	cellular	stimulation.	When	intracellular	sodium	ion	levels	rise,	for	example,	following
depolarisation,	these	transporters	can	operate	in	the	reverse	direction	to	allow	calcium	influx	and
sodium	efflux,	as	an	electrogenic	mechanism.	Structural	modelling	suggests	the	presence	of	9	TM
segments,	with	a	large	intracellular	loop	between	the	fifth	and	sixth	TM	segments	[1].
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